Joinn Laboratories (China) Co Ltd
Company Profile
Business description
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Contact
A5 Rongjing East Street
Beijing Economic-Technological Development Area
Beijing100176
CHNT: +86 1067869966
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
2,652
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,365.70 | 24.70 | 0.30% |
CAC 40 | 7,593.87 | 38.00 | 0.50% |
DAX 40 | 22,496.98 | 71.15 | 0.32% |
Dow JONES (US) | 40,752.96 | 83.60 | 0.21% |
FTSE 100 | 8,496.80 | 1.95 | 0.02% |
HKSE | 22,119.41 | 111.30 | 0.51% |
NASDAQ | 17,710.74 | 264.40 | 1.52% |
Nikkei 225 | 36,452.30 | 406.92 | 1.13% |
NZX 50 Index | 12,148.60 | 245.29 | 2.06% |
S&P 500 | 5,604.14 | 35.08 | 0.63% |
S&P/ASX 200 | 8,145.60 | 19.40 | 0.24% |
SSE Composite Index | 3,279.03 | 7.62 | -0.23% |